Catalyst Wire Dossier Catalyst Wire Dossier

PCSK9-targeted therapy

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCSK9-targeted therapy, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Real World Adherence of PCSK9 Targeted Therapy

See pricing